Pages that link to "Q36272425"

The following pages link to Impact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease. (Q36272425):

Displaying 32 items.

• A ferret model of COPD-related chronic bronchitis (Q27333635) (← links)
• Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records (Q37603569) (← links)
• Precision respiratory medicine and the microbiome (Q38678093) (← links)
• Bringing Stability to the Chronic Obstructive Pulmonary Disease Patient: Clinical and Pharmacological Considerations for Frequent Exacerbators (Q38751226) (← links)
• Sarcopenia and frailty in chronic respiratory disease. (Q38786398) (← links)
• Prediction and prevention of exacerbations and mortality in patients with COPD. (Q38823010) (← links)
• Duration of Hospitalization and Lung Function Deterioration as Predictors of Future Chronic Obstructive Pulmonary Disease Exacerbations (Q38895033) (← links)
• Misspecification of at-risk periods and distributional assumptions in estimating COPD exacerbation rates: The resultant bias in treatment effect estimation (Q39102942) (← links)
• Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease (Q39458622) (← links)
• Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease. (Q40598255) (← links)
• Guiding Principles for the Use of Nebulized Long-Acting Beta2-Agonists in Patients with COPD: An Expert Panel Consensus (Q41441617) (← links)
• The changing natural history of COPD: summary from the American Thoracic Society Meeting 2016 (Q42346105) (← links)
• Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant (Q42768766) (← links)
• Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study (Q47116435) (← links)
• What Can We Apply to Manage Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Acute Respiratory Failure? (Q47646670) (← links)
• Individualizing the selection of long-acting bronchodilator therapy for patients with COPD: considerations in primary care (Q47710084) (← links)
• Prediction of Chronic Obstructive Pulmonary Disease Exacerbation Frequency. Clinical Parameters Are Still Better Than Biomarkers (Q48234304) (← links)
• Oral Phosphodiesterase-4 Inhibitors for Chronic Obstructive Pulmonary Disease "Super Exacerbators". (Q48374095) (← links)
• Generic Respiratory Symptoms and Branded Lung Diseases: Same Difference? (Q50116497) (← links)
• Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD. (Q54998966) (← links)
• The Short-term Impact of Symptom-defined COPD Exacerbation Recovery on Health Status and Lung Function. (Q55006415) (← links)
• 'Exacerbation-free time' to assess the impact of exacerbations in patients with chronic obstructive pulmonary disease (COPD): a prospective observational study. (Q55007112) (← links)
• Validation of ACCESS: an automated tool to support self-management of COPD exacerbations (Q57816225) (← links)
• Adherence to GOLD guidelines in real-life COPD management in the Puglia region of Italy (Q58777676) (← links)
• Predictive factors for exacerbation and re-exacerbation in chronic obstructive pulmonary disease: an extension of the Cox model to analyze data from the Swiss COPD cohort (Q61799377) (← links)
• Use, utility and methods of telehealth for patients with COPD in England and Wales: a healthcare provider survey (Q64270425) (← links)
• The superexacerbator phenotype in patients with COPD: a descriptive analysis. (Q64907931) (← links)
• A randomized controlled trial for prevention of acute exacerbation of stable chronic obstructive pulmonary disease with acupoint application of traditional Chinese medicine: Study protocol clinical trial (SPIRIT Compliant) (Q90157661) (← links)
• Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation (Q91827968) (← links)
• Management of chronic obstructive pulmonary disease: A review focusing on exacerbations (Q92595453) (← links)
• Treatable traits in acute exacerbations of chronic airway diseases (Q92597822) (← links)
• Can Macrolide Antibiotics Prevent Hospital Readmissions? (Q92682298) (← links)